Levonorgestrel

左炔诺孕酮

Report date: 2026/05/25 20:02:40
NME

Base Information

Drug NameLevonorgestrel
Drug Alias NameLevonorgestrelum左旋甲炔诺酮Levonorgestrel IUSLevonovaMenopausal levonorgestrel system +[41] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionProgesterone receptor agonists
TargetsProgesterone receptor
Therapy Area/IndicationsContraceptionMenopausal symptomsDysmenorrhea +[12] 
Global Approved IndicationsContraceptionMenorrhagia
Approved Indications in ChinaContraceptionMenorrhagia
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryBelgiumCanadaBotswana +[29] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHra Pharma
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Texas MD Anderson Cancer CenterBayer OyBayer AG +[8] 
Inactive CompaniesSebela Women's Health IncWake Forest University Health SciencesDuramed Research, Inc +[9] 
Active IndicationsContraceptionMenorrhagiaEndometrial Hyperplasia +[6] 
Inactive IndicationsMenopausal symptomsDysmenorrheaColonic Neoplasms +[6] 

Other Information

ATC CodeG03AC03G03AD01
Related LinksWikipediaDrugBankKEGG